The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance (Englisch)
Freier Zugriff
- Neue Suche nach: Sellers, Cortlandt M.
- Neue Suche nach: Uhlig, Johannes
- Neue Suche nach: Ludwig, Johannes M.
- Neue Suche nach: Taddei, Tamar
- Neue Suche nach: Stein, Stacey M.
- Neue Suche nach: Lim, Joseph K.
- Neue Suche nach: Kim, Hyun S.
- Neue Suche nach: Sellers, Cortlandt M.
- Neue Suche nach: Uhlig, Johannes
- Neue Suche nach: Ludwig, Johannes M.
- Neue Suche nach: Taddei, Tamar
- Neue Suche nach: Stein, Stacey M.
- Neue Suche nach: Lim, Joseph K.
- Neue Suche nach: Kim, Hyun S.
In:
Cancer Medicine
;
8
, 13
;
5948-5958
;
2019
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance
-
Beteiligte:Sellers, Cortlandt M. ( Autor:in ) / Uhlig, Johannes ( Autor:in ) / Ludwig, Johannes M. ( Autor:in ) / Taddei, Tamar ( Autor:in ) / Stein, Stacey M. ( Autor:in ) / Lim, Joseph K. ( Autor:in ) / Kim, Hyun S. ( Autor:in )
-
Erschienen in:Cancer Medicine ; 8, 13 ; 5948-5958
-
Verlag:
-
Erscheinungsdatum:01.10.2019
-
Format / Umfang:11 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 8, Ausgabe 13
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 5821
-
Issue Information| 2019
- 5823
-
Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK‐positive non‐small cell lung cancer: A retrospective, real‐world studyYang, Guangjian / Ma, Di / Xu, Haiyan / Yang, Lu / Li, Junling / Xing, Puyuan / Hao, Xuezhi / Wang, Yan et al. | 2019
- 5831
-
Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancerPanebianco, Federica / Nikitski, Alyaksandr V. / Nikiforova, Marina N. / Nikiforov, Yuri E. et al. | 2019
- 5840
-
Cognitive and motor aspects of cancer‐related fatigueFeng, Li Rebekah / Regan, Jeniece / Shrader, Joseph A. / Liwang, Josephine / Ross, Alexander / Kumar, Saloni / Saligan, Leorey N. et al. | 2019
- 5850
-
Risk stratification for lung adenocarcinoma on EGFR and TP53 mutation status, chemotherapy, and PD‐L1 immunotherapyWu, Chih‐Hsun / Hwang, Ming‐Jing et al. | 2019
- 5862
-
Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resectionSong, Peipei / Midorikawa, Yutaka / Nakayama, Hisashi / Higaki, Tokio / Moriguchi, Masamichi / Aramaki, Osamu / Yamazaki, Shintaro / Aoki, Masaru / Teramoto, Kenichi / Takayama, Tadatoshi et al. | 2019
- 5872
-
Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based studyTao, Lianyuan / Yu, Haibo / Dong, Yadong / Tian, Guanjing / Ren, Zhiyuan / Li, Deyu et al. | 2019
- 5881
-
Adjuvant chemotherapy versus chemoradiation in high‐risk pancreatic adenocarcinoma: A propensity score‐matched analysisRaoof, Mustafa / Blakely, Andrew M. / Melstrom, Laleh G. / Lee, Byrne / Warner, Susanne G. / Chung, Vincent / Singh, Gagandeep / Chen, Yi‐Jen / Fong, Yuman et al. | 2019
- 5891
-
Phase I trial of TAK‐385 in hormone treatment‐naïve Japanese patients with nonmetastatic prostate cancerSuzuki, Hiroyoshi / Uemura, Hiroji / Mizokami, Atsushi / Hayashi, Narihiko / Miyoshi, Yasuhide / Nagamori, Satoshi / Enomoto, Yutaka / Akaza, Hideyuki / Asato, Takayuki / Kitagawa, Tadayuki et al. | 2019
- 5903
-
Hexokinase 2 dimerization and interaction with voltage‐dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancerFan, Kun / Fan, Zhiyao / Cheng, He / Huang, Qiuyi / Yang, Chao / Jin, Kaizhou / Luo, Guopei / Yu, Xianjun / Liu, Chen et al. | 2019
- 5916
-
Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver diseaseSellers, Cortlandt M. / Uhlig, Johannes / Ludwig, Johannes M. / Stein, Stacey M. / Kim, Hyun S. et al. | 2019
- 5930
-
The impact of angiogenesis inhibitors on survival of patients with small cell lung cancerShi, Xiaoshun / Dong, Xiaoying / Young, Sylvia / Chen, Allen Menglin / Liu, Xiguang / Zheng, Zhouxia / Huang, Kailing / Lu, Di / Feng, Siyang / Morahan, Grant et al. | 2019
- 5939
-
Real‐world outcomes of NSCLC patients receiving tissue or circulating tumor DNA‐guided osimertinib treatmentSu, Po‐Lan / Yang, Szu‐Chun / Chen, Yi‐Lin / Wu, Yi‐Lin / Lin, Chia‐Ying / Chang, Wei‐Yuan / Tseng, Yau‐Lin / Lai, Wu‐Wei / Ho, Chung‐Liang / Lin, Chien‐Chung et al. | 2019
- 5948
-
The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insuranceSellers, Cortlandt M. / Uhlig, Johannes / Ludwig, Johannes M. / Taddei, Tamar / Stein, Stacey M. / Lim, Joseph K. / Kim, Hyun S. et al. | 2019
- 5959
-
Burden of hospitalization in acute lymphoblastic leukemia patients treated with Inotuzumab Ozogamicin versus standard chemotherapy treatmentMarks, David I. / van Oostrum, Ilse / Mueller, Sabrina / Welch, Verna / Vandendries, Erik / Loberiza, Fausto R. / Böhme, Sarah / Su, Yun / Stelljes, Matthias / Kantarjian, Hagop M. et al. | 2019
- 5969
-
The effects and safety of PD‐1/PD‐L1 inhibitors on head and neck cancer: A systematic review and meta‐analysisWang, Bi‐Cheng / Cao, Ru‐Bo / Li, Pin‐Dong / Fu, Chen et al. | 2019
- 5979
-
Medication errors in a cohort of pediatric patients with acute lymphoblastic leukemia on remission induction therapy in a tertiary care hospital in MexicoVázquez‐Cornejo, Edmundo / Morales‐Ríos, Olga / Juárez‐Villegas, Luis E. / Islas Ortega, Erika J. / Vázquez‐Estupiñán, Felipe / Garduño‐Espinosa, Juan et al. | 2019
- 5988
-
Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastomaLee, Eudocia Q. / Muzikansky, Alona / Duda, Dan G. / Gaffey, Sarah / Dietrich, Jorg / Nayak, Lakshmi / Chukwueke, Ugonma N. / Beroukhim, Rameen / Doherty, Lisa / Laub, Caroline Kane et al. | 2019
- 5995
-
Identification of microRNA‐181 as a promising biomarker for predicting the poor survival in colorectal cancerPeng, Qiliang / Yao, Wenyan / Yu, Chenxiao / Zou, Li / Shen, Yuntian / Zhu, Yaqun / Cheng, Ming / Feng, Zhengyang / Xu, Bo et al. | 2019
- 6010
-
Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population‐based studyShi, Tao / Song, Xueru / Liu, Qin / Yang, Yang / Yu, Lixia / Liu, Baorui / Wei, Jia et al. | 2019
- 6021
-
Expression significance and potential mechanism of hypoxia‐inducible factor 1 alpha in patients with myelodysplastic syndromesLiang, Hai‐wei / Luo, Bin / Du, Li‐hua / He, Rong‐quan / Chen, Gang / Peng, Zhi‐gang / Ma, Jie et al. | 2019
- 6036
-
PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagusFassan, Matteo / Cavallin, Francesco / Guzzardo, Vincenza / Kotsafti, Andromachi / Scarpa, Melania / Cagol, Matteo / Chiarion‐Sileni, Vanna / Maria Saadeh, Luca / Alfieri, Rita / Castagliuolo, Ignazio et al. | 2019
- 6049
-
Feedback loop in miR‐449b‐3p/ADAM17/NF‐κB promotes metastasis in nasopharyngeal carcinomaFei, Qian / Du, Ming‐Yu / Qian, Lu‐Xi / Chen, Han‐Bo / Chen, Jie / Zhu, Hong‐Ming / Tian, Xiao‐Kang / Jiang, Ning / Gu, Jia‐Jia / He, Xia et al. | 2019
- 6064
-
Long noncoding RNA PART1 promotes progression of non‐small cell lung cancer cells via JAK‐STAT signaling pathwayZhu, Dengyan / Yu, Yang / Wang, Wei / Wu, Kai / Liu, Donglei / Yang, Yang / Zhang, Chunyang / Qi, Yu / Zhao, Song et al. | 2019
- 6082
-
LMP1‐positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signalingZhang, Zhibao / Yu, Xuehui / Zhou, Zhuan / Li, Bo / Peng, Jinwu / Wu, Xia / Luo, Xiangjian / Yang, Lifang et al. | 2019
- 6095
-
TP53 mediated miR‐3647‐5p prevents progression of cervical carcinoma by targeting AGR2Liu, Ronghua / Qian, Min / Zhou, Ting / Cui, Pengfei et al. | 2019
- 6106
-
Sam68 is required for the growth and survival of nonmelanoma skin cancerFu, Kai / Sun, Xin / Xia, Xue / Hobbs, Ryan P. / Guo, Yajuan / Coulombe, Pierre A. / Wan, Fengyi et al. | 2019
- 6114
-
Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectivesAbdi, Esmat / Latifi‐Navid, Saeid / Zahri, Saber / Yazdanbod, Abbas / Pourfarzi, Farhad et al. | 2019
- 6127
-
All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling studyHeijnsdijk, Eveline A. M. / Csanádi, Marcell / Gini, Andrea / ten Haaf, Kevin / Bendes, Rita / Anttila, Ahti / Senore, Carlo / de Koning, Harry J. et al. | 2019
- 6139
-
Risk of cancer and longest‐held occupations in Japanese workers: A multicenter hospital‐based case‐control studyKaneko, Rena / Zaitsu, Masayoshi / Sato, Yuzuru / Kobayashi, Yasuki et al. | 2019
- 6151
-
Genetic risk association of CDKN1A and RET gene SNPs with medullary thyroid carcinoma: Results from the largest MTC cohort and meta‐analysisMishra, Vasudha / Kowtal, Pradnya / Rane, Pallavi / Sarin, Rajiv et al. | 2019